Join
Live feed
·
PRReleasevia Quantisnow
Telesis Bio Inc. logo

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis

ByQuantisnow·Wall Street's wire, on your screen.
TBIO· Telesis Bio Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TBIO (Telesis Bio Inc.) and more on Quantisnow.